Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors

NCT02334930 · clinicaltrials.gov ↗

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

PEComa
Hemangioma

Interventions

OTHER: Biopsy

Sponsor

University Hospital, Bordeaux

Collaborators

[object Object]
[object Object]